The company plans to launch the system during the fourth quarter of this year. It is designed for patients with diabetes for safe treatment of diabetic neuropathy.
More Articles on Pain Management:
Central Phoenix Surgical Center Adds Progenitor Cell Therapy
Tennessee Grants 255 Pain Clinics Licenses Since New Law
Indiana Senator to Sponsor Bill Requiring Pain Clinic Owners be Physicians
NeuroMetrix Receives FDA 510(k) Clearance for Electrical Nerve Stimulator
NeuroMetrix has received FDA 510(k) approval for the SENSUS Pain Management Device intended for use as a transcutaneous electrical nerve stimulator for symptomatic relief and management of chronic intractable pain.
